R. Scott Huennekens

Former President & Chief Executive Officer at Volcano Corp.

R. Scott Huennekens

R. Scott Huennekens

Former President & Chief Executive Officer at Volcano Corp.

Overview
Career Highlights

Volcano Corp.
Verb Surgical, Inc.
Volcano Therapeutics, Inc.

RelSci Relationships

1288

Primary Location

San Diego, CA

Number of Boards

18

Birthday

1965

Age

54

Number of Awards

2

Relationships
RelSci Relationships are individuals R. Scott Huennekens likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chief Executive Officer at Metronom Health, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Endologix, Inc.

Relationship likelihood: Strong

Former Chairman & Chief Executive Officer at NuVasive Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Acutus Medical, Inc.

Relationship likelihood: Strong

Principal at Norwalk and Associates

Relationship likelihood: Strong

Chief Executive Officer & Director at Gene Sciences, Inc.

Relationship likelihood: Strong

Chief Academic Officer at Scripps Health

Relationship likelihood: Strong

Founder at EndoChoice Holdings, Inc.

Relationship likelihood: Strong

Former Partner at Sequoia Capital

Relationship likelihood: Strong

Operating Partner at Council Capital

Relationship likelihood: Strong

Paths to R. Scott Huennekens
Potential Connections via
Relationship Science
You
R. Scott Huennekens
Former President & Chief Executive Officer at Volcano Corp.
Education
M.B.A.
Class of 1991

Harvard Business School (HBS) is the graduate business school of Harvard University in Boston, Massachusetts, United States. The school offers a large full-time MBA program, doctoral programs, and many executive education programs. It owns Harvard Business School Publishing, which publishes business books, leadership articles, online management tools for corporate learning, case studies, and the monthly Harvard Business Review.

Class of 1986

University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.

Memberships
Member
Current

CHI was founded in 1993 as an independent 501(c)(6) organization devoted to researching and advocating policy to forward the interests of California’s biomedical community.

Member

YPO (Young Presidents’ Organization) connects people with successful young chief executives in a global network unlike any other. Founded in 1950 in New York City by a young president named Ray Hickok, the organization unites approximately 20,000 business leaders in more than 120 countries around a shared mission: Better Leaders Through Education and Idea Exchange. A great deal has changed since YPO’s founding but certain things have remained the same: the value of a peer network and trusted mentors, the importance of ongoing education, and the need for a “safe haven” where issues can be aired in an environment of confidentiality. Over the past six decades, YPO has maintained its core commitment to these ideals while embracing change with each successive generation of young business leaders.

Career History
President & Chief Executive Officer
Prior - 2015

Volcano Corporation develops, manufactures and commercializes a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The Company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab and single use disposable imaging catheters unique to our system. Our IVUS offerings are used by clinicians to measure the stage and severity of disease present in cardiac and peripheral vessels. IVUS is also used in post-stent placement procedures to confirm adequate expansion of the stent and full apposition to the vessel wall. Volcano IVUS offers unique features, including both phased array and rotational IVUS imaging catheters and advanced functionality options, such as VH® IVUS tissue characterization, ChromaFlo® and FFR (fractional flow reserve) technology. Volcano also provides functional management (FM) consoles and single-use pressure and flow guide wires, which are used to gauge the impact of arterial plaque on blood flow and pressure. The Company is also developing a line of ultra-high resolution Optical Coherence Tomography (OCT) systems and catheters, Forward Looking IVUS (FLIVUS) catheters and other image-guided therapy products. Currently, more than 3,900 Volcano s5/s5i IVUS and FM systems are installed worldwide, with approximately half of its revenues coming from outside the United States

Chairman, President & Chief Executive Officer
2015 - 2019
President & Chief Executive Officer
2002 - Prior

Volcano Corp. is a privately held medical device company founded in 2001. With over 400 worldwide employees, Volcano is focused on the discovery, development and commercialization of products for the detection and treatment of atherosclerosis and vulnerable plaques in the coronary and peripheral vascular systems. Volcano products include Intravascular Ultrasound (IVUS) systems and catheters, as well as physiology guide wires. With global distribution, VOLCANO is a leading provider of innovative diagnostic and therapy-guiding technologies to the interventional cardiology and peripheral vascular fields.

Boards & Committees
Director
Current

Scripps Translational Science Institute works to translate the latest advances in genomics into new diagnostics and treatments. In collaboration with Scripps Genomic Medicine, STSI researchers have collected DNA to generate a comprehensive human DNA bank. These samples could help identify genetic markers for cardiovascular disease, breast, colon and prostate cancers. and other conditions. STSI and Scripps Genomic Medicine investigators have also partnered with Affymetrix, Microsoft, and Navigenics to determine whether personal genomic testing motivates people to make positive lifestyle changes.

Member, Board of Advisors
Current

Fjord Ventures makes seed and early-stage investments in emerging life sciences companies, particularly those involved in medical technology. They look for companies in large and growing markets. The firm typically takes a seat on the Board of Directors of their portfolio companies.

Member, Board of Directors
2015 - 2015

Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company, which focuses on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The company engages in two programs including INOpulse and BCM. INOpulse is based on proprietary pulsatile nitric oxide delivery device. BCM is based on placebo-controlled clinical trial designed to support CE mark registration in the European Union. Bellerophon Therapeutics was founded in 2009 and is headquartered in Warren, NJ.

Member, Board of Directors
Current

The USC Marshall School of Business is a private research and academic institution at the University of Southern California. The Marshall School began as the College of Commerce and Business Administration in 1920. The Graduate School of Business Administration was established in 1960. It is the oldest AACSB accredited school of business in Southern California.

Director
Prior

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.

Political Donations
$1,000
2013

Senator from Oregon

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
2010
Ernst & Young - Entrepreneur of the Year
CPA (Certified Public Accountant)
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by R. Scott Huennekens. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of R. Scott Huennekens's profile does not indicate a business or promotional relationship of any kind between RelSci and R. Scott Huennekens.